Calcium electroporation: Evidence for differential effects in normal and malignant cell lines, evaluated in a 3D spheroid model

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Frandsen, Stine Krog ^a   Gibot, Laure ^b,c   Madi, Moinecha ^b,c   Gehl, Julie ^a   Rols, Marie Pierre ^b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BLEOMYCIN; CALCIUM;

ARTICLE; BLADDER CANCER CELL LINE; BLADDER CARCINOMA; BREAST ADENOCARCINOMA; BREAST CANCER CELL LINE; CALCIUM ELECTROPORATION; CELL DEATH; CELL SIZE; CELL VIABILITY; COLORECTAL CANCER CELL LINE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; ELECTROCHEMOTHERAPY; ELECTROPORATION; HUMAN; HUMAN CELL; SKIN FIBROBLAST; SPHEROID CELL; TRANSITIONAL CELL CARCINOMA; BIOLOGICAL MODEL; METABOLISM; MULTICELLULAR SPHEROID; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; CALCIUM; CELL LINE, TUMOR; ELECTROPORATION; HUMANS; MODELS, BIOLOGICAL; SPHEROIDS, CELLULAR;

EID: 84955448556     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144028     Document Type: Article

References (38)

1. Yarmush ML, Golberg A, Sersa G, Kotnik T, Miklavcic D. Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng. 2014; 16: 295-320. doi: 10.1146/annurev-bioeng-071813-104622 PMID: 24905876
2. Kee ST, Gehl J, and Lee EW. Clinical Aspects of Electroporation. 1st. New York: Springer; 2011.
3. Orlowski S, Belehradek J, Paoletti C, Mir LM. Transient Electropermeabilization of Cells in Culture - Increase of the Cyto-Toxicity of Anticancer Drugs. Biochemical Pharmacology. 1988; 37: 4727-4733. PMID: 2462423
4. Miklavcic D, Sersa G, Brecelj E, Gehl J, Soden D, Bianchi G et al. Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput. 2012; 50: 1213-1225. doi: 10.1007/s11517-012-0991-8 PMID: 23179413
5. Spratt DE, Gordon Spratt EA, Wu S, DeRosa A, Lee NY, Lacouture ME et al. Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. J Clin Oncol. 2014; 32: 3144-3155. doi: 10.1200/JCO.2014.55.4634 PMID: 25154827
6. Fyfe AJ, McKay P. Toxicities associated with bleomycin. J R Coll Physicians Edinb. 2010; 40: 213-215. doi: 10.4997/JRCPE.2010.306 PMID: 21127762
7. Carafoli E, Santella L, Branca D, Brini M. Generation, control, and processing of cellular calcium signals. Crit Rev Biochem Mol Biol. 2001; 36: 107-260. PMID: 11370791
8. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: Dynamics, homeostasis and remodelling. Nature Reviews Molecular Cell Biology. 2003; 4: 517-529. PMID: 12838335
9. Zhivotovsky B, Orrenius S. Calcium and cell death mechanisms: A perspective from the cell death community. Cell Calcium. 2011; 50: 211-221. doi: 10.1016/j.ceca.2011.03.003 PMID: 21459443
10. Frandsen SK, Gissel H, Hojman P, Tramm T, Eriksen J, Gehl J. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res. 2012; 72: 1336-1341. doi: 10.1158/0008-5472.CAN-11-3782 PMID: 22282658
11. Frandsen SK, Gissel H, Hojman P, Eriksen J, Gehl J. Calcium electroporation in three cell lines: a comparison of bleomycin and calcium, calcium compounds, and pulsing conditions. Biochim Biophys Acta. 2014; 1840: 1204-1208. doi: 10.1016/j.bbagen.2013.12.003 PMID: 24342489
12. Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V et al. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator (TM) by means of invasive or non-invasive electrodes. Eur J Cancer Supplements. 2006; 4: 14-25.
13. Electrochemotherapy for metastases in the skin from tumours of non-skin origin (IPG446). NICE - National Institute for Health and Care Excellence. 2013. Available: http://guidance.nice.org.uk/IPG446.
14. Gibot L, Rols MP. 3D spheroids' sensitivity to electric field pulses depends on their size. J Membr Biol. 2013; 246: 745-750. doi: 10.1007/s00232-013-9535-x PMID: 23519620
15. Gibot L, Wasungu L, Teissie J, Rols MP. Antitumor drug delivery in multicellular spheroids by electropermeabilization. J Control Release. 2013; 167: 138-147. doi: 10.1016/j.jconrel.2013.01.021 PMID: 23385033
16. Herbsleb M, Birkenkamp-Demtroder K, Thykjaer T, Wiuf C, Hein AM, Orntoft TF et al. Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells. BMC Med Genomics. 2008; 1: 31. doi: 10.1186/1755-8794-1-31 PMID: 18647386
17. Heller R, Coppola D, Pottinger C, Gilbert R, Jaroszeski MJ. Effect of electrochemotherapy on muscle and skin. Technology in cancer research & treatment. 2002; 1: 385-391.
18. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M et al. Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Ejc Supplements. 2006; 4: 3-13.
19. Agerholm-Larsen B, Iversen HK, Ibsen P, Moller JM, Mahmood F, Jensen KS et al. Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Res. 2011; 71: 3753-3762. doi: 10.1158/0008-5472.CAN-11-0451 PMID: 21507935
20. Matthiessen LW, Chalmers RL, Sainsbury DC, Veeramani S, Kessell G, Humphreys AC et al. Management of cutaneous metastases using electrochemotherapy. Acta Oncol. 2011; 50: 621-629. doi: 10.3109/0284186X.2011.573626 PMID: 21574833
21. Canatella PJ, Black MM, Bonnichsen DM, McKenna C, Prausnitz MR. Tissue electroporation: quantification and analysis of heterogeneous transport in multicellular environments. Biophys J. 2004; 86: 3260-3268. PMID: 15111439
22. Haynes MD, Martin TA, Jenkins SA, Kynaston HG, Matthews PN, Jiang WG. Tight junctions and bladder cancer (review). Int J Mol Med. 2005; 16: 3-9. PMID: 15942671
23. Vasquez JL, Gehl J, Hermann GG. Electroporation enhances mitomycin C cytotoxicity on T24 bladder cancer cell line: a potential improvement of intravesical chemotherapy in bladder cancer. Bioelectrochemistry. 2012; 88: 127-133. doi: 10.1016/j.bioelechem.2012.08.001 PMID: 22940093
24. Vasquez JL, Ibsen P, Lindberg H, Gehl J. In vitro and in vivo experiments on electrochemotherapy for bladder cancer. J Urol. 2015; 193: 1009-1015. doi: 10.1016/j.juro.2014.09.039 PMID: 25245485
25. Matthiessen LW, Johannesen HH, Hendel HW, Moss T, Kamby C, Gehl J. Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol. 2012; 51: 713-721. doi: 10.3109/0284186X.2012.685524 PMID: 22731832
26. Berchtold MW, Villalobo A. The many faces of calmodulin in cell proliferation, programmed cell death, autophagy, and cancer. Biochim Biophys Acta. 2014; 1843: 398-435. doi: 10.1016/j.bbamcr.2013.10.021 PMID: 24188867
27. Dubois C, Vanden Abeele F, Lehen'kyi V, Gkika D, Guarmit B, Lepage G et al. Remodeling of channelforming ORAI proteins determines an oncogenic switch in prostate cancer. Cancer Cell. 2014; 26: 19-32. doi: 10.1016/j.ccr.2014.04.025 PMID: 24954132
28. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol. 2010; 11: 700-714. doi: 10.1038/nrm2970 PMID: 20823910
29. Thompson GL, Roth CC, Dalzell DR, Kuipers M, Ibey BL. Calcium influx affects intracellular transport and membrane repair following nanosecond pulsed electric field exposure. J Biomed Opt. 2014; 19: 055005. doi: 10.1117/1.JBO.19.5.055005 PMID: 24825506
30. Mellgren RL, Miyake K, Kramerova I, Spencer MJ, Bourg N, Bartoli M et al. Calcium-dependent plasma membrane repair requires m- or mu-calpain, but not calpain-3, the proteasome, or caspases. Biochim Biophys Acta. 2009; 1793: 1886-1893. doi: 10.1016/j.bbamcr.2009.09.013 PMID: 19781581
31. Aung CS, Kruger WA, Poronnik P, Roberts-Thomson SJ, Monteith GR. Plasma membrane Ca2 +-ATPase expression during colon cancer cell line differentiation. Biochem Biophys Res Commun. 2007; 355: 932-936. PMID: 17321497
32. Papp B, Brouland JP, Arbabian A, Gelebart P, Kovacs T, Bobe R et al. Endoplasmic reticulum calcium pumps and cancer cell differentiation. Biomolecules. 2012; 2: 165-186. doi: 10.3390/biom2010165 PMID: 24970132
33. Stratigos A, Garbe C, Lebbe C, Malvehy J, Del M, V, Pehamberger H et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer. 2015; 51: 1989-2007. doi: 10.1016/j.ejca.2015.06.110 PMID: 26219687
34. Edhemovic I, Brecelj E, Gasljevic G, Marolt MM, Gorjup V, Mali B et al. Intraoperative electrochemotherapy of colorectal liver metastases. J Surg Oncol. 2014; 110: 320-327. doi: 10.1002/jso.23625 PMID: 24782355
35. Neal RE, Rossmeisl JH Jr., Garcia PA, Lanz OI, Henao-Guerrero N, Davalos RV. Successful treatment of a large soft tissue sarcoma with irreversible electroporation. J Clin Oncol. 2011; 29: e372-e377. doi: 10.1200/JCO.2010.33.0902 PMID: 21321291
36. Neal RE, Millar JL, Kavnoudias H, Royce P, Rosenfeldt F, Pham A et al. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation. Prostate. 2014; 74: 458-468. doi: 10.1002/pros.22760 PMID: 24442790
37. Scheffer HJ, Nielsen K, de Jong MC, van Tilborg AA, Vieveen JM, Bouwman AR et al. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc Interv Radiol. 2014; 25: 997-1011. doi: 10.1016/j.jvir.2014.01.028 PMID: 24656178
38. Jiang C, Davalos RV, Bischof JC. A review of basic to clinical studies of irreversible electroporation therapy. IEEE Trans Biomed Eng. 2015; 62: 4-20. PMID: 25389236